Skip to main content
Article thumbnail
Location of Repository

Effects of Weight Change on Clinical Outcomes in Overweight and Obese Patients with Acute Myocardial Infarction Who Underwent Successful Percutaneous Coronary Intervention

By Won Yu Kang, Seung Hwan Hwang, Sun Ho Hwang, Wan Kim, Keun Ho Park, Young Joon Hong, Ju Han Kim, Youngkeun Ahn and Myung Ho Jeong


Obesity is a well-established risk factor for many chronic disorders. However, the effect of weight change after acute myocardial infarction (AMI) is not well known. Among consecutive patients who underwent percutaneous coronary intervention between November 2005 and November 2007 due to AMI, patients who were overweight (23.0≤body mass index [BMI]<27.5 kg/m2, n=341) and obese (BMI≥27.5 kg/m2, n=80) were selected for analysis. According to weight change, the patients were divided into 4 groups: Group I (weight loss>5%, n=61), Group II (0%<weight loss≤5%, n=133), Group III (0%≤weight gain<5%, n=181), and Group IV (weight gain≥5%, n=46). We assessed the association between weight change and major adverse cardiac events (MACE). Greater weight loss was more frequent among older individuals (Group I: 64.1±12.4 years, II: 60.6±12.1 years, III: 59.0±11.9 years, IV: 61.4±10.6 years; p=0.028) and patients with diabetes (Group I: 34.4%, II: 27.1%, III: 21.2%, IV: 15.2%; p=0.009). However, there were no significant differences in baseline characteristics or in angiographic or procedural factors except for the proportions of patients with three-vessel disease, which were higher in patients with weight loss (Group I: 20.8%, II: 23.0%, III: 12.5%, IV: 11.6%; p=0.005). The group with greater weight loss had the highest MACE rate at the 12-month clinical follow-up (Group I: 36.9%, II: 25.0%, III: 25.9%, IV: 17.3%; p=0.020). Although weight loss after AMI appears to be associated with worse outcomes, it remains unclear whether the effect is of cardiac origin

Topics: Original Article
Publisher: Chonnam National University Medical School
OAI identifier:
Provided by: PubMed Central

Suggested articles


  1. Association of bodyweight with total mortality and with cardiovascular events in coronary artery disease: a systematic review of cohort studies.
  2. (1999). Comparison of the effects of losartan and captopril on mortality in patients after acute myocardial infarction: the OPTIMAAL trial design. Optimal Therapy in Myocardial Infarction with the Angiotensin II Antagonist Losartan.
  3. Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention 38 Weight Change after AMI strategies.
  4. Effect of ACE inhibition on neurohormones.
  5. (1992). Effects of the early administration of enalapril on mortality in patients with acute myocardial infarction.
  6. Impact of body mass index on in-hospital outcomes following percutaneous coronary intervention (report from the New York State Angioplasty Registry).
  7. Inflammation in acute coronary syndromes.
  8. INTERHEART Study Investigators. Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study.
  9. Korea Acute Myocardial Infarction Registry Investigators. Obesity paradox in Korean patients undergoing primary percutaneous coronary intervention in ST-segment elevation myocardial infarction.
  10. Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss.
  11. (1983). Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation
  12. Predictors of weight change in overweight patients with myocardial infarction.
  13. Prevalence and secular trends of excess body weight and impact on outcomes after myocardial infarction in the community.
  14. (1994). Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet
  15. The impact of body mass index on short- and long-term outcomes inpatients undergoing coronary revascularization. Insights from the bypass angioplasty revascularization investigation (BARI).
  16. The impact of obesity on mortality in UA/non-ST-segment elevation myocardial infarction.
  17. The impact of obesity on the short-term and long-term outcomes after percutaneous coronary intervention: the obesity paradox?
  18. The relationship between obesity and mortality in patients with heart failure.
  19. Topol EJ. Impact of body mass index on outcome after percutaneous coronary intervention (the obesity paradox).
  20. TRACE study group. Impact of obesity on long-term prognosis following acute myocardial infarction.
  21. Weight change after myocardial infarction--the Enhancing Recovery in Coronary Heart Disease patients (ENRICHD) experience.
  22. (1999). Weight loss increases and fat loss decreases all-cause mortality rate: results from two independent cohort studies.
  23. weight reduction and survival in heart failure.
  24. Weight-change as a prognostic marker in 12 550 patients following acute myocardial infarction or with stable coronary artery disease.

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.